• DoD bill will fund biological attack sensors

    The $636 billion Defense bill will send money to Michigan for bioterror research; $1.6 million will go to Dexter Research Center in Dexter, Michigan, to continue its development of a security sensor meant to protect military installations from chemical and biological attacks; Kettering University in Flint, Michigan will receive $1.6 million to help DoD with its Chemical Agent Fate Program

  • Maine to receive more than $3 million to aid bioterror research

    Research institutions in Maine will receive more than $3 million for bioterrorism research; a grant of $1.9 million will go to Orono Spectral Solutions to continue its development of an infrared detection system for chemical and biological agents; another $1.3 million will be set aside for Sensor Research & Development in Orono, for real time test monitoring of chemical agents, chemical agent stimulants and toxic industrial chemicals

  • Regional biodefense stockpiles could aid Europe in event of bioattack

    A plan for European preparation for a terrorist bioattacks calls for a regional stockpiling system within Europe; a Baltic stockpile, Nordic stockpile, and so on would be of great import and would aid in covering countries that have not expressed a desire to form their own stockpiles.

  • OSU president Burns Hargis defends anthrax research cancellation decision

    Hargis had ended an anthrax vaccine research project at OSU because it would have resulted in euthanizing baboons; he says he did not bow to pressures from animal rights activists – or from the wife of billionaire T. Boone Pickens, both OSU alumni and major donors to the school.

  • Military researcher infected with tularemia at research laboratory

    Researchers at U.S. Army Research Institute of Infectious Diseases has contracted tularemia; tularemia, which is not transmitted by person to person contact, is considered a potential agent of bioterrorism and biowarfare.

  • New guidelines for genetic screening to prevent bioterrorism split scientists

    As the production of very accurate and valid scientific results from genetic screening has become more common among synthetic-biology companies, a fear that this ability will allow bioterrorists to exploit the system has arisen; there is a disagreement over the best method of genetic screening.

  • Obama administration to review U.S. response to health threats

    Health and Human Services Secretary Kathleen Sebelius said that she ordered the evaluation of the U.S. responses to health threats in part because the H1N1 vaccine shortage had highlighted the nation’s dependence on antiquated technology

  • Potent new biodefense technology shows promise

    Medizone International’s AsepticSure technology continues to break the “6 log” decontamination barriers, this time with two very different spore forming bacteria, Claustridium difficile and Bacillis subtilis

  • Oklahoma State rejects anthrax study over euthanasia of primates

    The U.S. National Institutes of Health wanted OSU to conduct research on treatment for anthrax; the study involves baboons, which must be destroyed after anthrax exposure to ensure they do not infect others; In April, OSU announced that animals will no longer be euthanized in teaching labs at the veterinary school; measure was the result of pressure by Madeleine Pickens, the wife of billionaire benefactor and OSU alumnus T. Boone Pickens

  • Experts call for changes in U.S. vaccine creation process

    The current U.S. vaccine-manufacturing plan was developed prior to the cold war, and has never been updated; currently, the United States grows its vaccines in eggs over the course of six to eight months, and as there has been no real financial incentive to upgrade the vaccine making process, pharmaceutical manufacturers have instead focused on more profitable medications rather than vaccines

  • Governments worry about more cases of drug-resistant H1N1

    Health officials in the United Kingdom and the United States report the likely person-to-person spread of a drug-resistant strain of H1N1; most patients thus far infected with the strain have already been immune-deficient

  • Gene synthesis companies establish measures to counter bioterrorism

    The five largest synthetic DNA companies will establish common security measures to prevent the use of synthetic DNA by bioterrorists; among other things, the “Harmonized Screening Protocol” will screen gene sequences against a regulated pathogen database

  • Anticipating new diseases, bioterror methods

    The 150 researchers at the University of Florida’s Emerging Pathogens Institute work to anticipate and respond to new diseases and old ones — such as tuberculosis and cholera — that can turn into new threats or make a comeback

  • UIC to develop antibiotics against potential bioterrorism agents

    The University of Illinois at Chicago receives $4 million in stimulus package funds to develop new antibiotics to treat anthrax, tularemia and plague

  • NIAID allocated $208 million to fight emerging infectious diseases from bioterrorism

    Using its own research funds, augmented by stimulus package money, NIH awarded $208 million to two programs that support research better to understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism